← Back to Clinical Trials
Recruiting NCT06509672

NCT06509672 Combined Effects of Plyometric and Endurance Training Among Female Hockey Players

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06509672
Status Recruiting
Phase
Sponsor Riphah International University
Condition Plyometric Exercise
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-06-14
Primary Completion 2024-09-14

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 24 Years
Study Type INTERVENTIONAL
Interventions
Combined Plyometric and Endurance TrainingPlyometric TrainingEndurance training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-06-14 with a primary completion date of 2024-09-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Athletes need plyometric training as well as endurance training to enhance their speed, strength and agility in the field. Plyometric exercise involves stretching the muscle immediately before making a rapid concentric contraction. The combined action is commonly called a stretch-shortening cycle (SSC). Similar gains of maximal strength have been reported with traditional strength and plyometric training, but the latter approach appears to induce greater gains in muscle power. The combination of balance and muscle strength/power exercises seems to be an appropriate possibility, since both modalities induced adaptation on the neuromuscular level. A blocked combination of balance and muscle strength exercises effectively improve physical performance, and improvements in performance are more pronounced if balance exercises are followed by strength exercises than vice versa.

Eligibility Criteria

Inclusion Criteria: * Only female hockey players * Age 18-24 years * Athletes with at least one year experience in hockey * Athletes must be without previous experience in intense strength/endurance training * Only players who will participate in at all training sessions will be included in the statistical analysis Exclusion Criteria: * Participants having injuries resulting in loss of one or more hockey matches/ training sessions in the preceding three months prior to the initiation of the study * Participants with the history of systemic disease * Participants with history of lower extremity and lumber spine pathology * Participants with prior surgery history

Contact & Investigator

Central Contact

Muhammad Atif Javed, PP-DPT

✉ atif.javed@riphah.edu.pk

📞 +92 3317491071

Principal Investigator

Awishbah Khan

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06509672 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 24 Years, studying Plyometric Exercise. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06509672 currently recruiting?

Yes, NCT06509672 is actively recruiting participants. Contact the research team at atif.javed@riphah.edu.pk for enrollment information.

Where is the NCT06509672 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06509672 clinical trial?

NCT06509672 is sponsored by Riphah International University. The principal investigator is Awishbah Khan at Riphah International University. The trial plans to enroll 30 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology